NCT04628572View on ClinicalTrials.gov

Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections

CompletedOBSERVATIONAL
Enrollment

189

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
Gram Negative Infections
Interventions
DRUG

Ceftazidime-avibactam

Non-Interventional Study

Trial Locations (8)

201301

Metro Hospital, Noida

400078

Fortis Hospital, Bhandup West

411001

Grant Medical Foundation Ruby Hall Clinic, Pune

411004

Deenanath Mangeshkar Hospital and Research Centre, Erandwane,, PUNE

600006

Apollo Hospital, Chennai

600100

Gleneagles Global Hospitals, Chennai

700098

Amri Hospital, WEST Bengal

HYDERABAD

Apollo Hospital, Hyderabad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY